News you can use: health & drug safety updates


  • October 10, 2018

    President Donald Trump is expected to sign two bills Wednesday that ban "gag order" clauses in contracts between pharmacies and insurance companies or PBMs. Ronna Hauser, vice president of payment policy and regulatory affairs at the National Community Pharmacists Association, says many members of her group "say a PBM will call them with a warning if they are telling patients it’s less expensive" without insurance. She says pharmacists could be fined for violating their contracts and even dropped from insurance networks.

  • October 2, 2018

    The American Society of Health-System Pharmacists (ASHP) guidelines offer best practices and recommendations for avoiding medication errors in hospitals that highlight the leadership roles that pharmacists play and opportunities for them on interprofessional teams to limit errors. The guidelines urge organizations to have a comprehensive program that includes a medication safety head, an event reporting system, a collaborative medication safety team, and a continuous quality improvement philosophy about evaluation of errors and harm.

  • September 19, 2018

    About one in seven Americans has diabetes, totaling nearly 30 million people, according to the CDC. The agency noted about 14% of U.S. adults have diabetes, with 10% and 4% representing diagnosed and undiagnosed cases, respectively. The agency noted increasing obesity rates and an aging population are contributing to the rise of diabetes in the U.S. 

  • September 19, 2018

    The Department of Health and Human Services is awarding more than $1 billion in grants for states, communities and organizations working to address the opioid crisis, of which $930 million will be directed toward expansion of recovery and prevention services. HHS Secretary Alex Azar said in a statement that addressing the crisis with "all the resources possible" is a high priority for the Trump administration.

  • September 14, 2018

    Up to 6 million Americans could have opioid use disorder, which is nearly triple the government's estimate of 2.1 million, according to new research from McKinsey and Co. The report found undiagnosed opioid use disorder in 82 percent of Medicaid beneficiaries in Massachusetts who received high-dosage treatments of opioids. 

  • September 14, 2018

    The FDA Office of Women’s Health, in collaboration with the Center for Drug Evaluation and Research and Center for Tobacco Products, will be hosting a 2-day public meeting on Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex and Gender. The conference will include presentations by experts in the field of opioid and tobacco research, professional education, and clinical care on the biological (sex) and sociological (gender) influences on use, misuse, and recovery.

  • August 30, 2018

    This brochure, prepared by the American Pharmacists Association, describes biologic medications and a type of biologic known as biosimilars, which are highly similar to biologics but may be less expensive for patients. The information is designed to help you make informed decisions about your health care treatment options.

  • August 20, 2018

    SAMHSA announces the release of the Spanish translation of the updated Opioid Overdose Prevention Toolkit. This toolkit offers strategies to health care providers, communities, and local governments for developing practices and policies to help prevent opioid-related overdoses and deaths.

  • August 1, 2018

    NCPIE served as co-editor for a monthly column in Pharmacy Today (American Pharmacists Association) January 2013 - August 2018. The “One-to-One” column is intended to help develop pharmacists’ medication communication and counseling skills to promote safe and appropriate medicine use. All of the articles are located in the "NCPIE In the News" Tab

  • August 1, 2018

    This publication from the Geronterogical Society of America focuses on an analysis of safety risks associated with OTC analgesics, including cardiovascular risks, gastrointestinal risks, and renal risks. Information from national and international treatment guidelines for the use of OTC analgesics in older adults, and details regarding recent labeling changes for OTC analgesics, is provided.